Review



dce mri  (Bruker Corporation)


Bioz Verified Symbol Bruker Corporation is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 97
      Buy from Supplier

    Structured Review

    Bruker Corporation dce mri
    Dce Mri, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/MM2/pm41498583-406-21-25
    Average 97 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-09
    97/100 stars

    Images

    Related Articles

    Permeability:

    Article Title: Data-driven feedback augments ultrasound nanotheranostics in brain tumors
    Article Snippet: .. To access the vessel permeability in the brain, we measured the volume transfer constant, K trans , by performing DCE-MRI ( Pharmascan 7T, Bruker, IR, echo time, 2.5 ms; rep time, 1019.6 ms; flip angle, 30; FOV, 40 x 40 mm 2 ) after the last sonication. ..

    Article Title: Data-Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain.
    Article Snippet: .. Resonance Imaging (DCE-MRI) To access the vessel permeability in the brain, we measured the volume transfer constant, Ktrans , by performing DCE-MRI ( Pharmascan 7T, Bruker , IR, echo time, 2.5 ms; rep time, 1019.6 ms; flip angle, 30; FOV, 20 × 20 mm2 for mice, 35 × 35 mm2 for rats) after the last sonication. ..

    Article Title: Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain
    Article Snippet: .. To access the vessel permeability in the brain, we measured the volume transfer constant, K trans , by performing DCE‐MRI ( Pharmascan 7T, Bruker , IR, echo time, 2.5 ms; rep time, 1019.6 ms; flip angle, 30; FOV, 20 × 20 mm 2 for mice, 35 × 35 mm 2 for rats) after the last sonication. ..

    Sonication:

    Article Title: Data-driven feedback augments ultrasound nanotheranostics in brain tumors
    Article Snippet: .. To access the vessel permeability in the brain, we measured the volume transfer constant, K trans , by performing DCE-MRI ( Pharmascan 7T, Bruker, IR, echo time, 2.5 ms; rep time, 1019.6 ms; flip angle, 30; FOV, 40 x 40 mm 2 ) after the last sonication. ..

    Article Title: Data-Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain.
    Article Snippet: .. Resonance Imaging (DCE-MRI) To access the vessel permeability in the brain, we measured the volume transfer constant, Ktrans , by performing DCE-MRI ( Pharmascan 7T, Bruker , IR, echo time, 2.5 ms; rep time, 1019.6 ms; flip angle, 30; FOV, 20 × 20 mm2 for mice, 35 × 35 mm2 for rats) after the last sonication. ..

    Article Title: Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain
    Article Snippet: .. To access the vessel permeability in the brain, we measured the volume transfer constant, K trans , by performing DCE‐MRI ( Pharmascan 7T, Bruker , IR, echo time, 2.5 ms; rep time, 1019.6 ms; flip angle, 30; FOV, 20 × 20 mm 2 for mice, 35 × 35 mm 2 for rats) after the last sonication. ..

    Imaging:

    Article Title: Data-Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain.
    Article Snippet: .. Resonance Imaging (DCE-MRI) To access the vessel permeability in the brain, we measured the volume transfer constant, Ktrans , by performing DCE-MRI ( Pharmascan 7T, Bruker , IR, echo time, 2.5 ms; rep time, 1019.6 ms; flip angle, 30; FOV, 20 × 20 mm2 for mice, 35 × 35 mm2 for rats) after the last sonication. ..



    Similar Products

    ultrafast dce mri  (Philips Healthcare)
    86
    Philips Healthcare ultrafast dce mri
    Ultrafast Dce Mri, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/dce+measurement+mri/pm41823605-60-0-7
    Average 86 stars, based on 1 article reviews
    ultrafast dce mri - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dce mri measurement  (Philips Healthcare)
    86
    Philips Healthcare dce mri measurement
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri Measurement, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/dce+measurement+mri/pmc12913062-162-0-8
    Average 86 stars, based on 1 article reviews
    dce mri measurement - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dce mri  (Bruker Corporation)
    97
    Bruker Corporation dce mri
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/MM2/pm41498583-406-21-25
    Average 97 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-09
    97/100 stars
    		  Buy from Supplier
    dce mri  (Hirschmann)
    86
    Hirschmann dce mri
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri, supplied by Hirschmann, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/dce+mri/10__3390_slash_diagnostics16010136-103-20-0
    Average 86 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dce mri  (Jiangsu Hengrui Medicine)
    86
    Jiangsu Hengrui Medicine dce mri
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri, supplied by Jiangsu Hengrui Medicine, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/dce+mri/pmc12789915-71-1-8
    Average 86 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dce mri  (Bayer Schering Pharma)
    86
    Bayer Schering Pharma dce mri
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri, supplied by Bayer Schering Pharma, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/dce+mri/pm41135295-65-1-4
    Average 86 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dedicated dce mri software  (Siemens Healthineers)
    86
    Siemens Healthineers dedicated dce mri software
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dedicated Dce Mri Software, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/dedicated+software/pmc12346550-219-16-21
    Average 86 stars, based on 1 article reviews
    dedicated dce mri software - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).

    Journal: Frontiers in Oncology

    Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

    doi: 10.3389/fonc.2026.1714620

    Figure Lengend Snippet: Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).

    Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

    Techniques: Diffusion-based Assay

    Representative images of a non-TNBC lesion (Luminal B subtype, Invasive Ductal Carcinoma, Ki-67: 30%) in the left breast. The tumor exhibits an irregular shape with spiculation and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing a plateau pattern (Type II).

    Journal: Frontiers in Oncology

    Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

    doi: 10.3389/fonc.2026.1714620

    Figure Lengend Snippet: Representative images of a non-TNBC lesion (Luminal B subtype, Invasive Ductal Carcinoma, Ki-67: 30%) in the left breast. The tumor exhibits an irregular shape with spiculation and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing a plateau pattern (Type II).

    Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

    Techniques:

    Receiver operating characteristic (ROC) curves evaluating the diagnostic performance of different MRI parameters and models for distinguishing TNBC from non-TNBC. (A) ROC curves of individual DCE-MRI parameters (RE, ME, WI, WO) and their combination. (B) ROC curves of quantitative mapping parameters (Enhanced T1, ΔT1%, T2) and their combination. (C) Comparison of diagnostic performance among the DCE-MRI model, Quantitative Mapping model, and the Combined Model (DCE-MRI + Quantitative Mapping). The Combined Model achieved the highest Area Under the Curve (AUC = 0.977).

    Journal: Frontiers in Oncology

    Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

    doi: 10.3389/fonc.2026.1714620

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves evaluating the diagnostic performance of different MRI parameters and models for distinguishing TNBC from non-TNBC. (A) ROC curves of individual DCE-MRI parameters (RE, ME, WI, WO) and their combination. (B) ROC curves of quantitative mapping parameters (Enhanced T1, ΔT1%, T2) and their combination. (C) Comparison of diagnostic performance among the DCE-MRI model, Quantitative Mapping model, and the Combined Model (DCE-MRI + Quantitative Mapping). The Combined Model achieved the highest Area Under the Curve (AUC = 0.977).

    Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

    Techniques: Diagnostic Assay, Comparison